Archive: First Stage Investor

Premium
Deal Details Startup: Ayoba Security type: Crowd SAFE* Discount: 15% Valuation (cap): $7 million Minimum investment: $100 Where to invest: Republic Deadline: August 21, 2021 Note: Ayoba’s raise deadline is right around the corner, so if you’re interested in investing, make sure you get in by Saturday, August 21.  Once…
Premium

Crypto Insider: Crypto Portfolio Review

By Early Investing on August 16, 2021

It’s a good day for the crypto market. Bitcoin has gained 45% over the past month. But interpreting and understanding the crypto market is more of an art than a science. So in this episode of Crypto Insider, Vin Narayanan and Andy Gordon offer…
Premium
Upstack — the outstanding company I’m presenting to you today — finds, vets and provides companies with software developers from all over the world. It makes money from charging its clients an hourly rate that is about 37% more than the rate it pays its developers.  …
Premium
Congress is looking to crypto to help fund part of its $1 trillion infrastructure plan. But the language used in the infrastructure bill is so broad, it could spell bad news for the crypto universe.  Essentially, the bill requires anyone who…
Premium

Crypto Needs Its Own Bill Clinton

By Vin Narayanan on August 5, 2021

I don’t praise politicians often. And I rarely praise former President Bill Clinton. But in 1998, Clinton fought for and signed into law a 10-year moratorium on taxing internet access. The new law also prevented most e-commerce purchases from being taxed.  Clinton argued at the time…
Premium

Startup Insider: Trade Secrets vs. Patents

By Early Investing on August 2, 2021

A key part of a startup’s success is its defensibility — how it protects itself from the competition. It’s not enough for a company to offer a high-quality product. It needs to provide something that’s valuable and different from anything else out there. And…
Premium

New Pick: A Better, Fresher Take on Indoor Gardens

By Andy Gordon on July 29, 2021

Modgarden produces elegantly designed modular gardens so that people can grow fresh produce in their homes. It has garnered awards and a growing number of believers since its founding in 2015. And CEO and founder Aamar Khwaja feels great about what he’s doing. But just as importantly, he…
Premium

Startup Insider: Venture Capital Learns From Crowdfunding

By Early Investing on July 26, 2021

Equity crowdfunding is often seen as the balancing force to traditional venture capital. Venture capital is exclusive and focuses on writing large checks to a few companies. Equity crowdfunding prioritizes inclusivity and the power of many small investments added together.  But what if there were a…
Premium

Cityzenith Continues to Meet High Expectations

By Andy Gordon on July 22, 2021

I first recommended Cityzenith in August 2019. The company enables users to design, monitor, control, analyze, optimize, predict, and collaborate on physical assets all from one application. In other words, it uses “digital twin” technology — 3D virtual replicas of buildings, infrastructure and other physical assets…
Premium

Startup Insider: Reimagining the Private Markets

By Early Investing on July 19, 2021

Scott Kupor is one of the sharpest minds in venture capital. He’s the managing partner of Andreessen Horowitz and the author of Secrets of Sand Hill Road: Venture Capital and How to Get It. Kupor testified before Congress earlier…
Premium
There’s nothing more American than a comeback story. Rocky. Rudy. The Karate Kid. The business landscape is filled with successful comeback journeys. Walt Disney failed several times — and even went bankrupt once — before building the Disney empire. When Steve Jobs and Steve Wozniak founded Apple in 1976, it struggled.
Premium

Startup Insider: Filling the Biopharma Funding Gap

By Early Investing on July 12, 2021

There’s a funding gap in medical research known as the “valley of death.”  When research begins, it’s funded by government grants and nonprofits. But drug research and development is very time-intensive. It typically takes around 10 years to bring a drug to market — and nine…
Premium

Startup Insider: (Don’t) Follow Your Passion

By Early Investing on July 8, 2021

Venture capital legend Marc Andreessen — founder of Andreessen Horowitz and one of the earliest architects of the internet — has some advice for young people. Don’t follow your passion. “Your passion is likely more dumb and useless than anything else. Your passion should be your hobby, not your work.
Premium

This Data and Analytics Startup Is a Good Bet

By Vin Narayanan on July 1, 2021

If Warren Buffett reads this week’s startup investment recommendation, he might crack a smile. For years, we’ve poked fun at the Berkshire Hathaway CEO and his right-hand man Charlie Munger for their positions on bitcoin and missing out on the tech boom. But we…
Premium

Startup Insider: The Inside Track on Startup Accelerators

By Early Investing on June 28, 2021

When researching investment opportunities, investors need to review revenue numbers, market size, founder experience and other criteria. But what about accelerators? Some startups list their membership in a startup accelerator as a badge of honor. But what is an accelerator? And should investors take them into account when vetting startups?…
Premium
Andy Gordon first recommended Oracle Health to First Stage Investor members in February. The company is developing a long-term insertable cardiac monitor for heart failure.  Oracle has ambitious — but achievable — plans to get FDA clearance…